Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia

Published on Feb 1, 2016in Journal of The American Society of Nephrology10.121
路 DOI :10.1681/ASN.2014101025
Karl P. Schlingmann25
Estimated H-index: 25
(Boston Children's Hospital),
Justyna Ruminska3
Estimated H-index: 3
(UZH: University of Zurich)
+ 25 AuthorsMartin Konrad51
Estimated H-index: 51
(Boston Children's Hospital)
Sources
Abstract
Idiopathic infantile hypercalcemia (IIH) is characterized by severe hypercalcemia with failure to thrive, vomiting, dehydration, and nephrocalcinosis. Recently, mutations in the vitamin D catabolizing enzyme 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1) were described that lead to increased sensitivity to vitamin D due to accumulation of the active metabolite 1,25-(OH)2D3. In a subgroup of patients who presented in early infancy with renal phosphate wasting and symptomatic hypercalcemia, mutations in CYP24A1 were excluded. Four patients from families with parental consanguinity were subjected to homozygosity mapping that identified a second IIH gene locus on chromosome 5q35 with a maximum logarithm of odds (LOD) score of 6.79. The sequence analysis of the most promising candidate gene, SLC34A1 encoding renal sodium-phosphate cotransporter 2A (NaPi-IIa), revealed autosomal-recessive mutations in the four index cases and in 12 patients with sporadic IIH. Functional studies of mutant NaPi-IIa in Xenopus oocytes and opossum kidney (OK) cells demonstrated disturbed trafficking to the plasma membrane and loss of phosphate transport activity. Analysis of calcium and phosphate metabolism in Slc34a1-knockout mice highlighted the effect of phosphate depletion and fibroblast growth factor-23 suppression on the development of the IIH phenotype. The human and mice data together demonstrate that primary renal phosphate wasting caused by defective NaPi-IIa function induces inappropriate production of 1,25-(OH)2D3 with subsequent symptomatic hypercalcemia. Clinical and laboratory findings persist despite cessation of vitamin D prophylaxis but rapidly respond to phosphate supplementation. Therefore, early differentiation between SLC34A1 (NaPi-IIa) and CYP24A1 (24-hydroxylase) defects appears critical for targeted therapy in patients with IIH.
Figures & Tables
Download
馃摉 Papers frequently viewed together
References36
Newest
#1Jan HalbritterH-Index: 26
#2Michelle A. BaumH-Index: 28
Last. Friedhelm Hildebrandt (HHMI: Howard Hughes Medical Institute)H-Index: 102
view all 15 authors...
Nephrolithiasis is a prevalent condition with a high morbidity. Although dozens of monogenic causes have been identified, the fraction of single-gene disease has not been well studied. To determine the percentage of cases that can be molecularly explained by mutations in 1 of 30 known kidney stone genes, we conducted a high-throughput mutation analysis in a cohort of consecutively recruited patients from typical kidney stone clinics. The cohort comprised 272 genetically unresolved individuals (1...
Source
Compound heterozygous and homozygous (comp/hom) mutations in solute carrier family 34, member 3 (SLC34A3), the gene encoding the sodium (Na+)-dependent phosphate cotransporter 2c (NPT2c), cause hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a disorder characterized by renal phosphate wasting resulting in hypophosphatemia, correspondingly elevated 1,25(OH)2 vitamin D levels, hypercalciuria, and rickets/osteomalacia. Similar, albeit less severe, biochemical changes are observed in...
Source
#1Abbhirami Rajagopal (BCM: Baylor College of Medicine)H-Index: 8
#2Debora Braslavsky (CONICET: National Scientific and Technical Research Council)H-Index: 10
Last. Brendan Lee (BCM: Baylor College of Medicine)H-Index: 84
view all 13 authors...
Context: Two Argentinean siblings (a boy and a girl) from a nonconsanguineous family presented with hypercalcemia, hypercalciuria, hypophosphatemia, low parathyroid hormone (PTH), and nephrocalcinosis. Objective: The goal of this study was to identify genetic causes of the clinical findings in the two siblings. Design: Whole exome sequencing was performed to identify disease-causing mutations in the youngest sibling, and a candidate variant was screened in other family members by Sanger sequenci...
Source
Context: The discovery of hypercalcemic diseases due to loss-of-function mutations in 25-hydroxyvitamin D-24-hydroxylase has placed a new demand for sensitive and precise assays for 24,25-dihydroxyvitamin D [24,25-(OH)2D]. Objective: We describe a novel liquid chromatography and tandem mass spectrometry-based method involving derivatization with DMEQ-TAD {4-[2-(6,7-dimethoxy-4-methyl-3,4-dihydroquinoxalinyl)ethyl]-1,2,4-triazoline-3,5-dione} to simultaneously assay multiple vitamin D metabolites...
Source
#1Cristina Fenollar-Ferrer (MPG: Max Planck Society)H-Index: 7
#2Monica Patti (UZH: University of Zurich)H-Index: 7
Last. Lucy R. Forrest (MPG: Max Planck Society)H-Index: 38
view all 6 authors...
Phosphate plays essential biological roles and its plasma level in humans requires tight control to avoid bone loss (insufficiency) or vascular calcification (excess). Intestinal absorption and renal reabsorption of phosphate are mediated by members of the SLC34 family of sodium-coupled transporters (NaPi-IIa,b,c) whose membrane expression is regulated by various hormones, circulating proteins, and phosphate itself. Consequently, NaPi-II proteins are also potentially important pharmaceutical tar...
Source
#1Carsten A. Wagner (UZH: University of Zurich)H-Index: 79
#2Nati Hernando (UZH: University of Zurich)H-Index: 35
Last. J眉rg Biber (UZH: University of Zurich)H-Index: 76
view all 4 authors...
The SLC34 family of sodium-driven phosphate cotransporters comprises three members: NaPi-IIa (SLC34A1), NaPi-IIb (SLC34A2), and NaPi-IIc (SLC34A3). These transporters mediate the translocation of divalent inorganic phosphate (HPO4 2鈭) together with two (NaPi-IIc) or three sodium ions (NaPi-IIa and NaPi-IIb), respectively. Consequently, phosphate transport by NaPi-IIa and NaPi-IIb is electrogenic. NaPi-IIa and NaPi-IIc are predominantly expressed in the brush border membrane of the proximal tubul...
Source
#1Galina Nesterova (NIH: National Institutes of Health)H-Index: 8
#2May Christine V. Malicdan (NIH: National Institutes of Health)H-Index: 33
Last. William A. Gahl (NIH: National Institutes of Health)H-Index: 103
view all 15 authors...
Summary Background and objectives Elevated serum vitamin D with hypercalciuria can result in nephrocalcinosis and nephrolithiasis. This study evaluated the cause of excess 1,25-dihydroxycholecalciferol (1a,25(OH)2D3 )i n the development of those disorders in two individuals. Design, setting, participants, & measurements Two patients with elevated vitamin D levels and nephrocalcinosis or nephrolithiasis were investigated at the National Institutes of Health (NIH) Clinical Center and the NIH Undia...
Source
#1Monica Patti (UZH: University of Zurich)H-Index: 7
#2Chiara Ghezzi (UZH: University of Zurich)H-Index: 14
Last. Ian C. Forster (UZH: University of Zurich)H-Index: 46
view all 3 authors...
The SLC34 family of Na+-dependent inorganic phosphate cotransporters comprises two electrogenic isoforms (NaPi-IIa, NaPi-IIb) and an electroneutral isoform (NaPi-IIc). Both fulfill essential physiological roles in mammalian phosphate homeostasis. By substitution of three conserved amino acids, found in all electrogenic isoforms, at corresponding sites in NaPi-IIc, electrogenicity was re-established and the Na+/Pi stoichiometry increased from 2:1 to 3:1. However, this engineered electrogenic cons...
Source
#1Y. Yu (Harvard University)H-Index: 1
#2S.R. Sanderson (Horizon Health Network)H-Index: 1
Last. Clemens Bergwitz (Harvard University)H-Index: 26
view all 8 authors...
Homozygous and compound heterozygous mutations in SLC34A3, the gene encoding the sodium-dependent co-transporter NaPi-IIc, cause hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a disorder characterized by renal phosphate-wasting resulting in hypophosphatemia, elevated 1,25(OH)2 vitamin D levels, hypercalciuria, rickets/osteomalacia, and frequently kidney stones or nephrocalcinosis. Similar albeit less severe biochemical changes are also observed in heterozygous carriers, which ar...
Source
#1Karl P. Schlingmann (Boston Children's Hospital)H-Index: 25
#2Martin KaufmannH-Index: 22
Last. Martin KonradH-Index: 51
view all 17 authors...
Background Vitamin D supplementation for the prevention of rickets is one of the oldest and most effective prophylactic measures in medicine, having virtually eradicated rickets in North America. Given the potentially toxic effects of vitamin D, the recommendations for the optimal dose are still debated, in part owing to the increased incidence of idiopathic infantile hypercalcemia in Britain in the 1950s during a period of high vitamin D supplementation in fortified milk products. We investigat...
Source
Cited By124
Newest
Vitamin D metabolism represents a well-integrated, hormonally regulated endocrine unit interlinking calcium and phosphate metabolism. Pathophysiologic processes disturbing vitamin D metabolism comprise classic defects of vitamin D activation and action presenting as different forms of vitamin D-dependent rickets as well as disorders with increased vitamin D activity. The latter may result in hypercalcemia, hypercalciuria, and renal calcifications. Acquired and hereditary disorders causing hyperv...
Source
#1Evgenia Gurevich (BGU: Ben-Gurion University of the Negev)H-Index: 4
#2Shelly LeviH-Index: 2
Last. Miriam Davidovits (TAU: Tel Aviv University)H-Index: 19
view all 7 authors...
Purpose: Hypercalcemia with low parathyroid hormone (PTH) level, hypercalciuria, nephrocalcinosis, or nephrolithiasis, was recently reported as caused by mutations in CYP24A1 and SLC34A genes. These encode for vitamin D-24A-hydroxylase and for the renal phosphate transporters NaPiIIa and NaPiIIc, respectively. We aimed to describe the clinical course of these monogenic disorders in patients with and without found mutations during long-term follow-up. Methods: Ten patients with hypercalcemia, hyp...
Source
#1Andrea G. Cogal (Mayo Clinic)H-Index: 7
#2Jennifer Arroyo (Mayo Clinic)H-Index: 3
Last. Michelle A. Baum (Boston Children's Hospital)H-Index: 28
view all 21 authors...
Introduction null Because of phenotypic overlap between monogenic urinary stone diseases (USD), gene-specific analyses can result in missed diagnoses. We used targeted next generation sequencing (tNGS), including known and candidate monogenic USD genes, to analyze suspected primary hyperoxaluria (PH) or Dent disease (DD) patients genetically unresolved (negative; N) after Sanger analysis of the known genes. Cohorts consisted of 285 PH (PHN) and 59 DD (DDN) families. null null null Methods null V...
Source
#1Benjamin B. Sun (Biogen Idec)H-Index: 14
#2Mitja I. KurkiH-Index: 29
Last. Heiko Runz (Biogen Idec)H-Index: 34
view all 15 authors...
Abstract null Genome-wide association studies (GWAS) have identified thousands of genetic variants linked to the risk of human disease. However, GWAS have thus far remained largely underpowered to identify associations in the rare and low frequency allelic spectrum and have lacked the resolution to trace causal mechanisms to underlying genes. Here, we combined whole exome sequencing in 392,814 UK Biobank participants with imputed genotypes from 260,405 FinnGen participants (653,219 total individ...
Source
#1Arnaud MolinH-Index: 8
#2Sandrine Lemoine (University of Lyon)H-Index: 15
Last. Am茅lie Ryckwaert (University of Rennes)
view all 14 authors...
Mutations in CYP24A1 (vitamin D 24-hydroxylase) and SLC34A1 (renal phosphate transporter NPT2a) cause autosomal recessive Infantile Hypercalcemia type 1 and 2, illustrating links between vitamin D and phosphate metabolism. Patients may present hypercalciuria and alternate between chronic phases of normocalcemia with inappropriately high 1,25-(OH)2D and appropriately low PTH, and acute phases of hypercalcemia with suppressed PTH. Mutation in SLC34A3 and SLC9A3R1 have been associated with phosphat...
Source
#1Nina Lenherr-Taube (U of T: University of Toronto)H-Index: 2
#2Michelle Furman (U of T: University of Toronto)H-Index: 2
Last. Etienne Sochett (U of T: University of Toronto)H-Index: 35
view all 8 authors...
CONTEXT Idiopathic Infantile Hypercalcemia (IIH) is an uncommon disorder with variable clinical features. The natural history and response to dietary calcium and vitamin D restriction in IIH remains unclear. OBJECTIVE The aim of this study is to describe the clinical and biochemical response to dietary calcium and vitamin D restriction in a genetically characterized cohort of mild IIH. METHODS This is a longitudinal, observational cohort study of 20 children with mild IIH monitored for a median ...
Source
#1Nina Lenherr-Taube (U of T: University of Toronto)H-Index: 2
#2Edwin J. YoungH-Index: 10
Last. Kathleen M B Vinette (Wilmington University)H-Index: 1
view all 16 authors...
Context null Idiopathic Infantile Hypercalcemia (IIH), an uncommon disorder characterized by elevated serum concentrations of 1,25(OH)2D and low PTH levels, may present with mild to severe hypercalcemia during the first months of life. Biallelic variants in the CYP24A1 or SLC34A1 genes are associated with severe IIH. Little is known about milder forms. null Objective null To characterize the genetic associations and biochemical profile of mild IIH. null Methods null This is a cross-sectional stu...
Source
#4An Bael (Boston Children's Hospital)H-Index: 5
Deletions of the NaPi2a gene and mutations in the SLC34A gene should be considered in patients with atypical presentation, without phosphaturia, with mild hypo to normal phosphatemia, and nephrocalcinosis.
Source
#1Sarah M. Azer (Mayo Clinic)
#2Lisa E. Vaughan (Mayo Clinic)H-Index: 17
Last. David J. Sas (Mayo Clinic)H-Index: 9
view all 4 authors...
Context CYP24A1 encodes 24-hydroxylase, which converts 25(OH)D3 and 1,25(OH)2D3 to inactive metabolites. Loss-of-function variants in CYP24A1 are associated with 24-hydroxylase deficiency (24HD), characterized by hypercalcemia, nephrolithiasis, and nephrocalcinosis. We retrospectively reviewed laboratory, imaging, and clinical characteristics of patients with suspected or confirmed 24HD and patients with other vitamin D-mediated hypercalcemia disorders: sarcoidosis, lymphoma, and exogenous vitam...
Source
#1Daniele CappellaniH-Index: 8
Last. Filomena CetaniH-Index: 32
view all 3 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.